Davipharm Re-Certified by FDA Philippines for GMP Compliance
The FDA Philippines has re-certified Davipharm as a GMP manufacturer, granting us the Certificate of GMP Compliance (including non HP & HP Zone) at the start of 2025.
With this certification, we can register, manufacture, and release a wide range of products for export to the Philippines market.
This achievement marks a major milestone for Davipharm as we continue expanding into the Southeast Asian market, unlocking new business opportunities in our goal of becoming Vietnam’s leading pharmaceutical exporter.
